Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Yellin Lawrence Scott | 0001922420 | May-25-2022 | director, officer: Chief Financial Officer |
Bosita Renato V. Jr. | 0001718877 | Aug-01-2017 | director |
Kalra Ricky Raj S. | 0001718878 | Jul-13-2017 | director |
Reeg Christopher C | 0001688080 | Dec-19-2016 | director, 10 percent owner, officer: Chief Executive Officer |
Reeg Medical Industries, Inc. | 0001688081 | Dec-19-2016 | 10 percent owner |
McLaughlin William E III | 0001693498 | Dec-19-2016 | director |
NC 143 Family Holdings, LP | 0001688047 | Nov-17-2016 | 10 percent owner |
Brooks Mark W | 0001688048 | Nov-17-2016 | 10 percent owner |
NC 143 Family Holdings GP LLC | 0001693757 | Nov-17-2016 | 10 percent owner |
Medtech Family Trust | 0001693760 | Nov-17-2016 | 10 percent owner |
Pratt Chris | 0001609833 | May-28-2014 | director, 10 percent owner, officer: Chief Medical Officer |
Hexter David | 0001609870 | May-28-2014 | director, officer: Interim CFO |
Dei Randall | 0001609978 | May-28-2014 | director, officer: Medical Director of Podiatry |
Meeker D Alan | 0001609993 | May-28-2014 | director, 10 percent owner, officer: Chief Executive Officer |
Shelton Rusty | 0001610022 | May-28-2014 | director, 10 percent owner, officer: Chief Development Officer |
Brown Jonathan G | 0001610027 | May-28-2014 | director, 10 percent owner, officer: President and COO |
NAGELBERG DAVID S | 0000909440 | Jul-29-2003 | 10 percent owner |
DONEHEW ROBERT H | 0001105724 | Mar-14-2003 | director, officer: President and Treasurer |
MCCARTHY JOHN F III | 0001105726 | Mar-14-2003 | director, officer: Chairman and Secretary |
CHAROS ANTHONY | 0001114410 | Mar-12-2003 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Fuse Medical, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001564590-23-007256 (34 Act) Size: 6488 KB |
May-15-2023 | 23920623 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001193125-23-140798 (34 Act) Size: 272 KB |
May-10-2023 | 23907123 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-23-140777 (34 Act) Size: 497 KB |
May-10-2023 | 23906956 |
ARS | Document | Annual report to security holders Acc-no: 0001193125-23-140418 (34 Act) Size: 1072 KB |
May-10-2023 | 23905495 |
8-K | Document | Current report filing Acc-no: 0001564590-23-005823 (34 Act) Size: 392 KB |
Apr-18-2023 | 23825747 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001564590-23-005716 (34 Act) Size: 8898 KB |
Apr-14-2023 | 23819970 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001564590-23-005123 (34 Act) Size: 196 KB |
Apr-03-2023 | 23790257 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-038913 ( Act) Size: 6 KB |
Dec-16-2022 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-038910 ( Act) Size: 6 KB |
Dec-16-2022 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-038909 ( Act) Size: 6 KB |
Dec-16-2022 | |
8-K | Document | Current report filing Acc-no: 0001564590-22-038196 (34 Act) Size: 194 KB |
Nov-22-2022 | 221411395 |
8-K | Document | Current report filing Acc-no: 0001564590-22-038045 (34 Act) Size: 712 KB |
Nov-18-2022 | 221402949 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-036239 ( Act) Size: 4 KB |
Nov-17-2022 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001564590-22-037641 (34 Act) Size: 7116 KB |
Nov-14-2022 | 221386472 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001564590-22-029139 (34 Act) Size: 7007 KB |
Aug-11-2022 | 221156390 |
8-K | Document | Current report filing Acc-no: 0001564590-22-024362 (34 Act) Size: 165 KB |
Jun-28-2022 | 221046407 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000899243-22-019710 ( Act) Size: 3 KB |
May-26-2022 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001564590-22-019837 (34 Act) Size: 6759 KB |
May-12-2022 | 22917687 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001193125-22-146162 (34 Act) Size: 971 KB |
May-10-2022 | 22909064 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001193125-22-146158 (34 Act) Size: 492 KB |
May-10-2022 | 22909046 |
Recent 20 filings. View all Fuse Medical, Inc. filings
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by